Injury risk factors and barriers to their mitigation for women playing rugby league: a Delphi study.


Journal

Journal of sports sciences
ISSN: 1466-447X
Titre abrégé: J Sports Sci
Pays: England
ID NLM: 8405364

Informations de publication

Date de publication:
Jul 2022
Historique:
pubmed: 14 6 2022
medline: 20 8 2022
entrez: 13 6 2022
Statut: ppublish

Résumé

This study aimed to 1) develop a consensus (≥70% agreement between experts) on injury risk factors specific to women playing rugby league, 2) establish the importance of the identified injury risk factors and the feasibility of mitigating these risk factors and 3) establish context specific barriers to injury risk management. Aim 1: A Delphi panel, consisting of 12 experts in rugby league and injury (e.g., physiotherapists, research scientists) were asked to identify injury risk factors specific to women playing rugby league. Aim 2: seven coaches of women's rugby league teams were asked to rate each risk factor that achieved consensus by their importance and feasibility to manage. Aim 3: Coaches reported barriers which restrict injury risk factor mitigation. Of the 53 injury risk factors which achieved consensus, the five injury risk factors with the highest combination of importance and feasibility ratings were: "poor tackle technique", "a lack of pre-season intensity", "training session are too short", "the current medical standards", and "limited access to physiotherapists". Following the identification of injury risk factors, their feasibility to manage and context specific barriers, this study proposes three constraint driven, integrated solutions which may reduce the barriers which limit injury risk factor management.

Identifiants

pubmed: 35694782
doi: 10.1080/02640414.2022.2085433
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1436-1449

Auteurs

Sean Scantlebury (S)

Carnegie Applied Rugby Research (CARR) centre, Carnegie School of Sport, Leeds Beckett University, Leeds, UK.
England Performance Unit, Rugby Football League, Leeds, UK.

Carlos Ramirez (C)

Carnegie Applied Rugby Research (CARR) centre, Carnegie School of Sport, Leeds Beckett University, Leeds, UK.
England Performance Unit, Rugby Football League, Leeds, UK.

Cloe Cummins (C)

Carnegie Applied Rugby Research (CARR) centre, Carnegie School of Sport, Leeds Beckett University, Leeds, UK.
School of Science and Technology, University of New England, Armidale, Australia.
National Rugby League, Armidale, Australia.

Keith Stokes (K)

Department for Health, University of Bath, Bath, UK.
Rugby Football Union, Twickenham, UK.

Jason Tee (J)

Carnegie Applied Rugby Research (CARR) centre, Carnegie School of Sport, Leeds Beckett University, Leeds, UK.
Department of Physiology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.

Clare Minahan (C)

Griffith Sports Science, Griffith University, Australia.

Stacey Emmonds (S)

Carnegie Applied Rugby Research (CARR) centre, Carnegie School of Sport, Leeds Beckett University, Leeds, UK.
England Performance Unit, Rugby Football League, Leeds, UK.

Sam McCormack (S)

Carnegie Applied Rugby Research (CARR) centre, Carnegie School of Sport, Leeds Beckett University, Leeds, UK.
England Performance Unit, Rugby Football League, Leeds, UK.

Gemma Phillips (G)

England Performance Unit, Rugby Football League, Leeds, UK.
Hull Kingston Rovers, Hull, UK.

Ben Jones (B)

Carnegie Applied Rugby Research (CARR) centre, Carnegie School of Sport, Leeds Beckett University, Leeds, UK.
England Performance Unit, Rugby Football League, Leeds, UK.
School of Science and Technology, University of New England, Armidale, Australia.
Griffith Sports Science, Griffith University, Australia.
Leeds Rhinos Rugby League club, Leeds, UK.
Division of Exercise Science and Sports Medicine, Department of Human Biology, Faculty of Health Sciences, The University of Cape Town and the Sports Science Institute of South Africa, Cape Town, South Africa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH